Kamran Musayev, Firdovsi Ibrahimov, Isfendiyar Ismayilov, Oktay Musayev, Shahana Elesgerli, Tofik Cahangırov, Ferid Aliyev

Short and long-term follow-up after coronary artery bypass surgery or percutaneous coronary intervention among elderly patients with multivessel disease

Aim: Compared to young patients, elderly patients are more prone to multivessel coronary artery disease, have more calcific coronary vessels, and experience greater delays in receiving medical help. Notably, differences in in-hospital and post-discharge mortality and morbidity rates have been observed between patient who underwent percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG). The present study primarily aimed to determine differences between CABG and PCI (with new-generation drugeluting stents) among elderly patients with unstable angina pectoris (USAP) or non-ST segment elevation myocardial infarction (NSTEMI) and intermediate SYNTAX score. Materials and Methods: This study evaluated the 441 consecutive elderly patients with with USAP or NSTEMI divided into two groups as PCI or CABG were retrospectively evaluated and followed up for 30 days and 5 years. All clinical incidents, such as all-cause mortality, cardiac death, myocardial infarction (MI),stroke, revascularization and stent thrombosis were recorded. Results: Among the include patients, 200 received PCI (%45.4) and 241 (%54.6) received CABG. 1.3% and 4.8% of the patients in the PCI and CABG group developed a stroke, respectively (p=0.048). The PCI group (23%) exhibited a higher major adverse cardiovascular events percentage than the CABG group (18.7%), albeit not significantly (p=0.264). Repeat revascularization was required in 20 (10.1%) and 18 patients (10.8%) in the PCI and CABG group, respectively (p = 0.337). Among the included patients, 10.3% of those who underwent PCI developed MI, whereas only of 5.3% of those who underwent CABG developed the same (p=0.045). All-cause mortality rates at the 5-year follow-up were 12.7% (25 patients) and 9.1% (21 patients) in the PCI and CABG group, respectively (p=0.225). Accordingly, no difference in all-cause mortality between both groups was found during the first 30 days following revascularization (p=0.13). Moreover, Kaplan–Meier survival analysis showed a difference between PCI and CABG during the 5-year observation period. Conclusion: No difference in all-cause mortality and repeat revascularization over a 5-year follow-up period was observed between the PCI and CABG groups. However, the CABG group had higher stroke rates, whereas the PCI group had higher MI rates.

PDF

___

1. Frye RL, Alderman EL, Andrews K, et al. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) investigators. N Engl J Med 1996;335:217-25.
2. Park S-J, Ahn J-M, Kim Y-H, et al. Trial of everolimuseluting stents or bypass surgery for coronary disease. N Engl J Med 2015;372:1204-12.
3. Mullany CJ, Mock MB, Brooks MM, et al. Effect of age in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. Ann Thorac Surg 1999;67:396-403.
4. Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med 2012;366:1467-76.
5. Serruys PW, Ong AT, van Herwerden LA, et al. Fiveyear outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005;46:575-81.
6. Mohr FW, Morice M-C, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. The Lancet 2013;381:629-638.
7. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 2018;72:2231-64.
8. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ ESC Guidelines for the management of arterial hypertension. Arterial Hypertension 2013;17:69-168.
9. Members ATF, Rydén L, Grant PJ, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J Cardiovasc Pharmacother 2013;34:3035-87.
10. Reiner Ž, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J Cardiovasc Pharmacother 2011;32:1769-818.
11. Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronaryartery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
12. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233-71.
13. Silber S, Windecker S, Vranckx P, et al. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stentrelated outcomes from the RESOLUTE All Comers trial. The Lancet 2011;377:1241-7.
14. Hannan EL, Zhong Y, Berger PB, et al. Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients≥ 75 years of age. Am J Cardiol 2014;113:803- 8.
15. Ahn J-M, Park D-W, Lee CW, et al. Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease: patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST trials. JACC Cardiovasc Interv 2017;10:1415-24.
16. Yanagawa B, Algarni KD, Yau TM, et al. Improving results for coronary artery bypass graft surgery in the elderly. Eur J Cardiothorac Surg 2012;42:507-12.
17. Tarakji KG, Sabik JF, Bhudia SK, et al. Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. Jama 2011;305:381-90.
18. Marui A, Kimura T, Tanaka S, et al. Comparison of frequency of postoperative stroke in off-pump coronary artery bypass grafting versus on-pump coronary artery bypass grafting versus percutaneous coronary intervention. Am J Cardiol 2012;110:1773-8.
19. Yamaji K, Shiomi H, Morimoto T, et al. Effects of age and sex on clinical outcomes after percutaneous coronary intervention relative to coronary artery bypass grafting in patients with triple-vessel coronary artery disease. Circulation 2016;133:1878-91.